Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
By A. Hodsman, D. Bauer, D. Dempster, L. Dian, D. Hanley, S. T. Harris, D. Kendler, M. McClung, P. Miller, W. Olszynski and 2 more. Endocrine reviews, 2005
718 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Orthopedics and Sports Medicine
View Paper: https://www.semanticscholar.org/paper/f5f06b7f51e8b3b033e3e104c3c7c09540be08ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- The Pharmacological Potential of Rutin (2016, background): “' Parathyroid hormones are only classes of agents that ‘stimulate bone formation’ (Hodsman et al., 2005).”
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. (2007, background): “The findings in these two mouse models of attenuated negative feedback signaling support the notion that the degree of bone anabolism caused by intermittent PTH can be limited by the ability of the hormone to also stimulate bone resorption – a phenomenon that may contribute to the gradual loss of an”